Home » Stocks » SPNE

SeaSpine Holdings Corporation (SPNE)

Stock Price: $19.59 USD 0.45 (2.35%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
After-hours: $19.50 -0.09 (-0.46%) Jul 30, 7:43 PM
Market Cap 649.63M
Revenue (ttm) 160.19M
Net Income (ttm) -43.35M
Shares Out 27.91M
EPS (ttm) -1.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $19.59
Previous Close $19.14
Change ($) 0.45
Change (%) 2.35%
Day's Open 19.22
Day's Range 18.99 - 20.00
Day's Volume 109,935
52-Week Range 9.38 - 22.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

CARLSBAD, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

4 days ago - GlobeNewsWire

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 days ago - Zacks Investment Research

CARLSBAD, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

6 days ago - GlobeNewsWire

The FDA has given 510(k) clearance to SeaSpine Holdings Corporation's (NASDAQ:SPNE) 7D Percutaneous Spine Module for minimally invasive surgery.  This news follows SeaSpine's recent acquisition of 7D Su...

3 weeks ago - Benzinga

CARLSBAD, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

3 weeks ago - GlobeNewsWire

CARLSBAD, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

1 month ago - GlobeNewsWire

CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

1 month ago - GlobeNewsWire

CARLSBAD, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

1 month ago - GlobeNewsWire

CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, ...

2 months ago - GlobeNewsWire

CARLSBAD, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, ...

2 months ago - GlobeNewsWire

CARLSBAD, Calif., May 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, ...

2 months ago - GlobeNewsWire

NEW YORK, May 5, 2021 /PRNewswire/ -- DLA Piper represented SeaSpine Holdings Corporation (NASDAQ: SPNE) in its recent public offering of 5,175,000 shares of its common stock at a price of $19.50 per sh...

2 months ago - PRNewsWire

Reaffirms 2021 Financial Outlook Reaffirms 2021 Financial Outlook

2 months ago - GlobeNewsWire

Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.

Other stocks mentioned: CFMS, IART, NUVA, OFIX, ZBH
3 months ago - Zacks Investment Research

CARLSBAD, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

3 months ago - GlobeNewsWire

CARLSBAD, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

3 months ago - GlobeNewsWire

CARLSBAD, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the...

3 months ago - GlobeNewsWire

CARLSBAD, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the...

3 months ago - GlobeNewsWire

SeaSpine (SPNE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

3 months ago - Zacks Investment Research

Provides Additional Financial Guidance for Pending Acquisition of 7D Surgical Provides Additional Financial Guidance for Pending Acquisition of 7D Surgical

3 months ago - GlobeNewsWire

CARLSBAD, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

4 months ago - GlobeNewsWire

CARLSBAD, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

4 months ago - GlobeNewsWire

SeaSpine (SPNE) delivered earnings and revenue surprises of -42.31% and -2.16%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Shares of SeaSpine Holdings (NASDAQ:SPNE) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 17.78% year over year to ($0.37), which mi...

5 months ago - Benzinga

Reports Record Quarterly Revenue, Driven by U.S. Sales Channel Reports Record Quarterly Revenue, Driven by U.S. Sales Channel

5 months ago - GlobeNewsWire

CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

5 months ago - GlobeNewsWire

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

CARLSBAD, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

5 months ago - GlobeNewsWire

CARLSBAD, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

6 months ago - GlobeNewsWire

CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

6 months ago - GlobeNewsWire

CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

7 months ago - GlobeNewsWire

CARLSBAD, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

7 months ago - GlobeNewsWire

SeaSpine Holdings Corporation (SPNE) CEO Keith Valentine on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

SeaSpine (SPNE) delivered earnings and revenue surprises of 20.00% and 0.25%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Shares of SeaSpine Holdings (NASDAQ:SPNE) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 52.94% year over year to ($0.24), which beat ...

8 months ago - Benzinga

CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

8 months ago - GlobeNewsWire

CARLSBAD, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

8 months ago - GlobeNewsWire

Study shows cells in cellular bone matrix products did not improve fusion SeaSpine's DBM outperformed the tested CBM products Study shows cells in cellular bone matrix products did not improve fusion Se...

8 months ago - GlobeNewsWire

SeaSpine (SPNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

CARLSBAD, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

9 months ago - GlobeNewsWire

CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

9 months ago - GlobeNewsWire

CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

9 months ago - GlobeNewsWire

CARLSBAD, Calif., Oct. 02, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

9 months ago - GlobeNewsWire

Does SeaSpine Holdings (SPNE) have what it takes to be a top stock pick for momentum investors? Let's find out.

9 months ago - Zacks Investment Research

As of late, it has definitely been a great time to be an investor in SeaSpine.

10 months ago - Zacks Investment Research

SeaSpine Holdings is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

10 months ago - Zacks Investment Research

CARLSBAD, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorde...

10 months ago - GlobeNewsWire

CARLSBAD, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorde...

10 months ago - GlobeNewsWire

CARLSBAD, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder...

11 months ago - GlobeNewsWire

CARLSBAD, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder...

11 months ago - GlobeNewsWire

About SPNE

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone ... [Read more...]

Industry
Medical Devices
CEO
Keith Valentine
Employees
421
Stock Exchange
NASDAQ
Ticker Symbol
SPNE
Full Company Profile

Financial Performance

In 2020, SPNE's revenue was $154.35 million, a decrease of -2.98% compared to the previous year's $159.08 million. Losses were -$43.18 million, 9.94% more than in 2019.

Financial Statements

Analyst Forecasts

According to 8 analysts, the average rating for SPNE stock is "Strong Buy." The 12-month stock price forecast is 28.03, which is an increase of 43.08% from the latest price.

Price Target
$28.03
(43.08% upside)
Analyst Consensus: Strong Buy